Cross John Harry III
SEC insider (Form 3/4/5 filer). CIK 0001806763. Chief Financial Officer at Senti Biosciences, Inc. (SNTI) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Mar 7, 2025. Located in PRINCETON,, NJ.
Companies Cross John Harry III has filed insider reports for
- Senti Biosciences, Inc. (SNTI): Officer, Chief Financial Officer
- Sonnet BioTherapeutics Holdings, Inc. (SONN): Officer, Chief Financial Officer
Cross John Harry III
CIK: 0001806763
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
